Quantum Biopharma Ltd. financial data

Symbol
QNTM on Nasdaq
Location
Toronto
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 28 Mar 2025

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $744,802 USD 2158%
General And Administrative Expense $3,250,030 USD 5.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $17,119,224 USD -2%
Liabilities $6,678,992 USD 46%